Cargando…
An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result
The purpose of this study is to compare the treatment outcome of different radiation doses of elective neck irradiation (ENI) in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT). In total, 504 patients with nondisseminated NPC who underwent magnetic resona...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313001/ https://www.ncbi.nlm.nih.gov/pubmed/28178144 http://dx.doi.org/10.1097/MD.0000000000006036 |
_version_ | 1782508293122424832 |
---|---|
author | Hung, Tsung-Min Fan, Kang-Hsing Chen, Eric Yen-Chao Lin, Chien-Yu Kang, Chung-Jan Huang, Shiang-Fu Liao, Chun-Ta Ng, Shu-Hang Wang, Hung-Ming Chang, Joseph Tung-Chieh |
author_facet | Hung, Tsung-Min Fan, Kang-Hsing Chen, Eric Yen-Chao Lin, Chien-Yu Kang, Chung-Jan Huang, Shiang-Fu Liao, Chun-Ta Ng, Shu-Hang Wang, Hung-Ming Chang, Joseph Tung-Chieh |
author_sort | Hung, Tsung-Min |
collection | PubMed |
description | The purpose of this study is to compare the treatment outcome of different radiation doses of elective neck irradiation (ENI) in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT). In total, 504 patients with nondisseminated NPC who underwent magnetic resonance imaging before radical IMRT between 2000 and 2008 were retrospectively reviewed. The patients were classified into 2 groups based on the ENI dose: low ENI when the ENI dose was 46 Gy (n = 446) and high ENI when the ENI doses were 50 to 60 Gy (n = 58). All the patients in both the groups received a median dose of 72 Gy to the gross tumor and involved nodes. The fraction size was 2 Gy per fraction. Matching was performed between low ENI and high ENI in a 2:1 ratio, and the matching criteria were N-stage, T-stage, treatment modality, pathology classification, sex, and age. The median follow-up for all patients was 63.5 months. In all patients, the 5-year progression-free survival (PFS), local control (LC), regional control (RC), distant metastasis-free survival (DMFS), overall survival (OS), and cancer-specific survival (CSS) for low ENI and high ENI patients were 69.0% and 63.2% (P = 0.331), 89.0% and 83.9% (P = 0.235), 90.1% and 85.2% (P = 0.246), 86.8% and 76.6% (P = 0.056), 77.5% and 80.8% (P = 0.926), and 84.4% and 82.5% (P = 0.237), respectively. In the matched-pair analysis, the 5-year PFS, LC, RC, DMFS, OS, and CSS for matched low ENI and high ENI patients were 74.1% and 63.2% (P = 0.134), 92.0% and 83.9% (P = 0.152), 90.1% and 85.2% (P = 0.356), 86.2% and 76.6% (P = 0.125), 87.0% and 80.8% (P = 0.102), and 88.6% and 82.5% (P = 0.080), respectively. In the multivariable analysis for all patients, the ENI group was not a significant factor for PFS, LC, RC, DMFS, OS, and CSS. A low ENI dose of 46 Gy in 23 fractions is feasible in NPC patients treated with IMRT, and this concept should be validated in the prospective studies. |
format | Online Article Text |
id | pubmed-5313001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-53130012017-02-21 An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result Hung, Tsung-Min Fan, Kang-Hsing Chen, Eric Yen-Chao Lin, Chien-Yu Kang, Chung-Jan Huang, Shiang-Fu Liao, Chun-Ta Ng, Shu-Hang Wang, Hung-Ming Chang, Joseph Tung-Chieh Medicine (Baltimore) 3500 The purpose of this study is to compare the treatment outcome of different radiation doses of elective neck irradiation (ENI) in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT). In total, 504 patients with nondisseminated NPC who underwent magnetic resonance imaging before radical IMRT between 2000 and 2008 were retrospectively reviewed. The patients were classified into 2 groups based on the ENI dose: low ENI when the ENI dose was 46 Gy (n = 446) and high ENI when the ENI doses were 50 to 60 Gy (n = 58). All the patients in both the groups received a median dose of 72 Gy to the gross tumor and involved nodes. The fraction size was 2 Gy per fraction. Matching was performed between low ENI and high ENI in a 2:1 ratio, and the matching criteria were N-stage, T-stage, treatment modality, pathology classification, sex, and age. The median follow-up for all patients was 63.5 months. In all patients, the 5-year progression-free survival (PFS), local control (LC), regional control (RC), distant metastasis-free survival (DMFS), overall survival (OS), and cancer-specific survival (CSS) for low ENI and high ENI patients were 69.0% and 63.2% (P = 0.331), 89.0% and 83.9% (P = 0.235), 90.1% and 85.2% (P = 0.246), 86.8% and 76.6% (P = 0.056), 77.5% and 80.8% (P = 0.926), and 84.4% and 82.5% (P = 0.237), respectively. In the matched-pair analysis, the 5-year PFS, LC, RC, DMFS, OS, and CSS for matched low ENI and high ENI patients were 74.1% and 63.2% (P = 0.134), 92.0% and 83.9% (P = 0.152), 90.1% and 85.2% (P = 0.356), 86.2% and 76.6% (P = 0.125), 87.0% and 80.8% (P = 0.102), and 88.6% and 82.5% (P = 0.080), respectively. In the multivariable analysis for all patients, the ENI group was not a significant factor for PFS, LC, RC, DMFS, OS, and CSS. A low ENI dose of 46 Gy in 23 fractions is feasible in NPC patients treated with IMRT, and this concept should be validated in the prospective studies. Wolters Kluwer Health 2017-02-10 /pmc/articles/PMC5313001/ /pubmed/28178144 http://dx.doi.org/10.1097/MD.0000000000006036 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 3500 Hung, Tsung-Min Fan, Kang-Hsing Chen, Eric Yen-Chao Lin, Chien-Yu Kang, Chung-Jan Huang, Shiang-Fu Liao, Chun-Ta Ng, Shu-Hang Wang, Hung-Ming Chang, Joseph Tung-Chieh An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result |
title | An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result |
title_full | An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result |
title_fullStr | An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result |
title_full_unstemmed | An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result |
title_short | An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result |
title_sort | elective radiation dose of 46 gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a long-term follow-up result |
topic | 3500 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313001/ https://www.ncbi.nlm.nih.gov/pubmed/28178144 http://dx.doi.org/10.1097/MD.0000000000006036 |
work_keys_str_mv | AT hungtsungmin anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT fankanghsing anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT chenericyenchao anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT linchienyu anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT kangchungjan anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT huangshiangfu anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT liaochunta anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT ngshuhang anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT wanghungming anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT changjosephtungchieh anelectiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT hungtsungmin electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT fankanghsing electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT chenericyenchao electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT linchienyu electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT kangchungjan electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT huangshiangfu electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT liaochunta electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT ngshuhang electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT wanghungming electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult AT changjosephtungchieh electiveradiationdoseof46gyisfeasibleinnasopharyngealcarcinomatreatedbyintensitymodulatedradiotherapyalongtermfollowupresult |